{
  "id": 17228539,
  "title": "AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan",
  "url": "https://urgent.news/2026/10/30/astrazeneca-profit-jumps-23-on-cancer-drugs-as-it-unveils-major-17228539",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-30T12:17:41.000Z",
  "source": {
    "name": "Euronews Business",
    "slug": "euronews-business",
    "url": "https://www.euronews.com/2026/10/30/astrazeneca-profit-jumps-23-on-cancer-drugs-as-it-unveils-major-savings-plan"
  },
  "original_language": "en",
  "account": null,
  "summary": "AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}